Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00120341 · ClinicalTrials.gov registry record · Phase 4
Anodyne Therapy in Diabetic Sensory Neuropathy
A Phase 4 study, sponsored by Scott and White Hospital & Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00120341 is a Phase 4 study that has completed, run by Scott and White Hospital & Clinic. The registered enrollment target is 60 participants.
The verdict
NCT00120341, a Phase 4 study, has completed, sponsored by Scott and White Hospital & Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if the use of a series of the Anodyne Therapy System in-home treatments over a 90-day period will improve peripheral sensation and quality of life in persons with diabetes mellitus.
Interventions
- DEVICE Anodyne Therapy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2005-04 |
| Est. Completion | 2006-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00120341
The ClinicalTrials.gov registry entry for NCT00120341 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scott and White Hospital & Clinic, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Anodyne Therapy System is the first listed.
NCT00120341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00120341 about?
NCT00120341 is a clinical study titled "Anodyne Therapy in Diabetic Sensory Neuropathy". The purpose of this research study is to determine if the use of a series of the Anodyne Therapy System in-home treatments over a 90-day period will improve peripheral sensation and quality of life in persons with diabetes mellitus.
What is the current status of trial NCT00120341?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2005-04. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00120341?
The interventions under investigation include: Anodyne Therapy System (DEVICE).
Who is sponsoring clinical trial NCT00120341?
This trial is sponsored by Scott and White Hospital & Clinic, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.